Introduction. Pharmacokinetics of psychotropic agents: why and how they are relevant to treatment
Preskorn, S.H.
Journal of Clinical Psychiatry 54 Suppl: 3-7; Discussion 55-6
1993
ISSN/ISBN: 0160-6689 PMID: 8407857 Document Number: 7023
Document emailed within 1 workday
Related Documents
Preskorn, S.H. 1993: Pharmacokinetics of antidepressants: why and how they are relevant to treatment Journal of Clinical Psychiatry 54(Suppl): 14-34; Discussion 55-56Cocchi, R.; Mastruzzo, A.; Ciccone, A.; Osvaldi, M.L. 1977: 1-glutamine and dipropylacetic acid as subsidiary psychotropic agents in the treatment of psychiatric in-patients. Effect on the neuroleptic consumption L'Encephale 3(2): 121-132
Sellers, E.M. 1984: Ethanol-psychotropic drug interactions: pharmacokinetics Psychopharmacology Bulletin 20(3): 497-499
Shoaf, S.E.; Linnoila, M. 1991: Interaction of ethanol and smoking on the pharmacokinetics and pharmacodynamics of psychotropic medications Psychopharmacology Bulletin 27(4): 577-594
Stapleton, G.; Schröder-Bäck, P.; Laaser, U.; Meershoek, A.; Popa, D. 2014: Global health ethics: an introduction to prominent theories and relevant topics Global Health Action 7: 23569
Logothetis, C.J. 1999: Introduction: a therapeutically relevant framework for the classification of human prostate cancer Seminars in Oncology 26(4): 369-374
Haffen, E.; Sechter, D. 2004: Prescription and monitoring of psychotropic agents La Revue du Praticien 54(10): 1119-1127
Leygonie, F.; Scherrer, J. 1975: Effect of psychotropic agents on sleep International Journal of Neurology 10(1-4): 158-171
Levine, J.; Schiele, B.C.; Bouthilet, L. 1971: Establishing the efficacy of psychotropic agents Psychopharmacology Bulletin 7(3): 16-22
Sno, H.N.; Schuitenmaker, M.G. 2000: Non-oral routes of administration of psychotropic agents Nederlands Tijdschrift Voor Geneeskunde 144(3): 116-120
Raiskiĭ, V.A. 1970: Psychotropic agents in the clinical aspects of internal diseases Fel'dsher i Akusherka 35(1): 24-29
Burger, D.M.; Hoetelmans, R.M.; Koopmans, P.P.; Meenhorst, P.L.; Mulder, J.W.; Hekster, Y.A.; Beijnen, J.H. 1997: Clinically relevant drug interactions with antiretroviral agents Antiviral Therapy 2(3): 149-165
Radev, R. 1976: Electrophysiological aspects in the mechanism of action of some psychotropic drug agents Eksperimentalna Meditsina i Morfologiia 15(1): 46-52
Machula, A.I.; Morozov, I.I.; Barkov, N.K. 1993: A systems analysis of the effect of psychotropic agents on the learning process Eksperimental'naia i Klinicheskaia Farmakologiia 56(1): 62-64
Bhattacharya, S.K.; Satyan, K.S.; Ramanathan, M. 1999: Experimental methods for evaluation of psychotropic agents in rodents: II-Antidepressants Indian Journal of Experimental Biology 37(2): 117-123
Miyauchi, A. 2016: Relationship of pharmacokinetics, changes of bone turnover markers and BMD/fractures efficacy during treatment with anabolic agents;Teriparatide daily and once weekly subcutaneous injections Clinical Calcium 26(11): 1583-1595
Puech, A. 1994: The significance of evaluating animal behavior with psychotropic drugs and especially with antidepressive agents L'Encephale 20(Special Issue 2): 247-249
Stefancich, G.; Artico, M.; Corelli, F.; Silvestri, R.; de Feo, G.; Mazzanti, G.; Durando, L.; Palmery, M. 1985: New psychotropic agents. I. Synthesis and pharmacologic activity of derivatives of 5H-imidazo-[2,1-c][1,4]benzodiazepine Il Farmaco; Edizione Scientifica 40(6): 429-441
Neubert, R.H.H.; Gensbügel, C.; Jäckel, A.; Wartewig, S. 2006: Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails Die Pharmazie 61(7): 604-607
Bavoux, F.; Lanfranchi, C.; Olive, G.; Asensi, D.; Dulac, O.; Francoual, C.; Huault, G.; Olivier, C.; Seilaniantz, M.; Castot, A.; Medernach, C.; Benzaken, C.; Efthymiou, M.L. 1981: Adverse effects on newborns from intra uterine exposure to benzodiazepines and other psychotropic agents Therapie 36(3): 305-312